Clinical Trial Search

Primary: Sensitivity of Detection of HSV DNA by GeneXpert PCR From Specimens Obtained From the Genital Tract of Non-pregnant Women in STI Clinics, as Compared With HSV Culture…

Primary: 1-Hour Change in Postprandial Plasma Glucose (PPG) — 105.15; 154.24; 99.90; 114.94 mg/dL — p=.008

Primary: Mean Change From Baseline Using Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) Total Scores During the Study: Unadjusted Analysis and ANCOVA (LOCF) (FAS)…

Primary: Part A: Percentage of Participants Who Experienced Treatment-Emergent Adverse Events (TEAEs) — 25.0; 50.0; 37.5; 0 percentage of participants

Primary: Change From Baseline Air Challenge — -1.643; -1.500 Units on a scale

Primary: Summary of Treatment-Emergent Adverse Event Reported by >10% of Participants Following Ascending Doses of DS-1040b and a Placebo in Participants With Acute Ischemic…

Primary: Pathogens of Healthcare Associated Pneumonia, Measured by the Number of Participants — 15; 51; 195; 269 Participants

Primary: Number of Participants With Haematoma — 10; 23; 6; 11 Participants — p=<0.0001

Primary: Percent Change in Post-procedural IL-6 Concentration From Baseline to 30 Min -1 hr After PCI — 0; 20 % change — p=0.31

Primary: Preferred Brand Smoke Intake (CO) — 3.30; 3.16; 9.07; 10.54 ppm

Primary: 6 Minute Walk Distance — 230 meters

Primary: Change From Baseline in Autism Diagnostic Observation Schedule(ADOS) at 4 Month — 3.3; 3.6; 7.5; 8.8 score on a scale

Primary: Depression Symptoms Over Time — -0.062 Units on a Scale

Primary: Time to Development of Diabetes — 323; 293 Participants

Primary: Percent of Subjects With Worst-Itch Numeric Rating Scale 4-point Responder at Week 10 — 26.45; 20.31 Percentage of subjects — p=0.229